Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1901 1
1938 1
1947 1
1950 2
1951 1
1952 1
1953 2
1956 2
1957 1
1958 6
1959 3
1960 2
1961 4
1962 1
1963 3
1964 4
1965 1
1966 6
1967 5
1968 6
1969 2
1970 2
1971 4
1972 6
1973 4
1974 5
1975 8
1976 2
1977 4
1978 8
1979 3
1980 5
1981 3
1982 8
1983 6
1984 5
1985 3
1986 2
1987 2
1988 4
1989 5
1990 3
1991 6
1992 3
1993 6
1994 6
1995 4
1996 12
1997 6
1998 10
1999 8
2000 12
2001 16
2002 25
2003 24
2004 22
2005 17
2006 21
2007 29
2008 23
2009 29
2010 28
2011 30
2012 35
2013 32
2014 55
2015 51
2016 49
2017 53
2018 59
2019 50
2020 43
2021 59
2022 82
2023 79
2024 62
2025 38

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,117 results

Results by year

Filters applied: . Clear all
Page 1
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Hummel HD, Kufer P, Grüllich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Döcke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC. Hummel HD, et al. Among authors: buck a. Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10. Immunotherapy. 2021. PMID: 33172323 Free article. Clinical Trial.
A prognostic neural epigenetic signature in high-grade glioma.
Drexler R, Khatri R, Sauvigny T, Mohme M, Maire CL, Ryba A, Zghaibeh Y, Dührsen L, Salviano-Silva A, Lamszus K, Westphal M, Gempt J, Wefers AK, Neumann JE, Bode H, Hausmann F, Huber TB, Bonn S, Jütten K, Delev D, Weber KJ, Harter PN, Onken J, Vajkoczy P, Capper D, Wiestler B, Weller M, Snijder B, Buck A, Weiss T, Göller PC, Sahm F, Menstel JA, Zimmer DN, Keough MB, Ni L, Monje M, Silverbush D, Hovestadt V, Suvà ML, Krishna S, Hervey-Jumper SL, Schüller U, Heiland DH, Hänzelmann S, Ricklefs FL. Drexler R, et al. Among authors: buck a. Nat Med. 2024 Jun;30(6):1622-1635. doi: 10.1038/s41591-024-02969-w. Epub 2024 May 17. Nat Med. 2024. PMID: 38760585 Free PMC article.
CXCR4-targeted theranostics in oncology.
Buck AK, Serfling SE, Lindner T, Hänscheid H, Schirbel A, Hahner S, Fassnacht M, Einsele H, Werner RA. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4133-4144. doi: 10.1007/s00259-022-05849-y. Epub 2022 Jun 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 35674738 Free PMC article. Review.
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.
Martins TA, Kaymak D, Tatari N, Gerster F, Hogan S, Ritz MF, Sabatino V, Wieboldt R, Bartoszek EM, McDaid M, Gerber A, Buck A, Beshirova A, Heider A, Shekarian T, Mohamed H, Etter MM, Schmassmann P, Abel I, Boulay JL, Saito Y, Mariani L, Guzman R, Snijder B, Weiss T, Läubli H, Hutter G. Martins TA, et al. Among authors: buck a. Nat Commun. 2024 Nov 9;15(1):9718. doi: 10.1038/s41467-024-54129-w. Nat Commun. 2024. PMID: 39521782 Free PMC article.
Cranioencephalic functional lymphoid units in glioblastoma.
Dobersalske C, Rauschenbach L, Hua Y, Berliner C, Steinbach A, Grüneboom A, Kokkaliaris KD, Heiland DH, Berger P, Langer S, Tan CL, Stenzel M, Landolsi S, Weber F, Darkwah Oppong M, Werner RA, Gull H, Schröder T, Linsenmann T, Buck AK, Gunzer M, Stuschke M, Keyvani K, Forsting M, Glas M, Kipnis J, Steindler DA, Reinhardt HC, Green EW, Platten M, Tasdogan A, Herrmann K, Rambow F, Cima I, Sure U, Scheffler B. Dobersalske C, et al. Among authors: buck ak. Nat Med. 2024 Oct;30(10):2947-2956. doi: 10.1038/s41591-024-03152-x. Epub 2024 Jul 31. Nat Med. 2024. PMID: 39085419 Free PMC article.
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity.
Lee S, Weiss T, Bühler M, Mena J, Lottenbach Z, Wegmann R, Sun M, Bihl M, Augustynek B, Baumann SP, Goetze S, van Drogen A, Pedrioli PGA, Penton D, Festl Y, Buck A, Kirschenbaum D, Zeitlberger AM, Neidert MC, Vasella F, Rushing EJ, Wollscheid B, Hediger MA, Weller M, Snijder B. Lee S, et al. Among authors: buck a. Nat Med. 2024 Nov;30(11):3196-3208. doi: 10.1038/s41591-024-03224-y. Epub 2024 Sep 20. Nat Med. 2024. PMID: 39304781 Free PMC article.
Theranostics in Hematooncology.
Buck AK, Serfling SE, Kraus S, Samnick S, Dreher N, Higuchi T, Rasche L, Einsele H, Werner RA. Buck AK, et al. J Nucl Med. 2023 Jul;64(7):1009-1016. doi: 10.2967/jnumed.122.265199. Epub 2023 Jun 8. J Nucl Med. 2023. PMID: 37290799 Free PMC article.
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Peluso MJ, Ryder D, Flavell RR, Wang Y, Levi J, LaFranchi BH, Deveau TM, Buck AM, Munter SE, Asare KA, Aslam M, Koch W, Szabo G, Hoh R, Deswal M, Rodriguez AE, Buitrago M, Tai V, Shrestha U, Lu S, Goldberg SA, Dalhuisen T, Vasquez JJ, Durstenfeld MS, Hsue PY, Kelly JD, Kumar N, Martin JN, Gambhir A, Somsouk M, Seo Y, Deeks SG, Laszik ZG, VanBrocklin HF, Henrich TJ. Peluso MJ, et al. Among authors: buck am. Sci Transl Med. 2024 Jul 3;16(754):eadk3295. doi: 10.1126/scitranslmed.adk3295. Epub 2024 Jul 3. Sci Transl Med. 2024. PMID: 38959327 Free PMC article.
Adrenal functional imaging.
Werner RA, Schirbel A, Buck AK, Fassnacht M, Hahner S. Werner RA, et al. Among authors: buck ak. Presse Med. 2022 Jun;51(2):104114. doi: 10.1016/j.lpm.2022.104114. Epub 2022 Feb 4. Presse Med. 2022. PMID: 35131316
1,117 results